JPRN-jRCT1080221410未知1 期
Exploratory pharmacokinetic study of yokukansan (TJ-54) in healthy volunteers.
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 44age old（—）
- 性别
- All
入选标准
- •1)Subject body mass index (BMI) is between 18.5 and 25 kg/m2
- •2)Willing and able to provide written, signed informed consent
排除标准
- •1) Subjects with a history of allergic reactions to drugs (including Kampo medicines) and food(s).
- •2) Female subjects who are pregnant, breastfeeding or planning to become pregnant.
- •3) Subjects who have participated in another clinical trial within the past 4 months.
- •4) Subjects who have had their blood drawn or donated > 400mL of blood within 3 months prior to study drug administration.
- •5) Subject with history of significant hepatic, cardiovascular or hematological disease.
- •6) Subjects with hepatic steatosis.
- •7) Current physical dependence and habitual use of alcohol and/or tobacco products.
- •8) Long-term use of medications (e.g., antipsychotic, antifungal, antihypertensive, Kampo medicine, etc.).
- •9) Use of supplements containing Glycyrrhiza, Cnidium rhizome, Angelicae root, Bupleuri root, Uncaria hook, Atractylodis lancea rhizome, Poria Sclerotium,
- •within 3 days prior to study drug administration.
- •10) Use of any agent within 7 days prior to study drug administration.
- •11) Subjects with abnormal clinical laboratory values inappropriate for the study in the opinion of the principal investigator/subinvestigator.
- •12) Subjects who are deemed ineligible for other reasons by the principal investigator/subinvestigator.
研究者
相似试验
未知
1 期
Exploratory pharmacokinetic study of Rikkunshito (TJ-43) in healthy volunteers.Healthy volunteersJPRN-jRCT1080221759Tsumura & Co.4
尚未招募
1 期
To see the effect of Herbo mineral and modified Herbo mineral drug in the management of constipatioCTRI/2024/07/071097ational Institute of Ayurveda
已完成
1 期
A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal FunctionRenal InsufficiencyNCT03189498Janssen Pharmaceutica N.V., Belgium38
进行中（未招募）
1 期
A study to assess the pharmacokinetics and safety of tocilizumab in patients with Active Systemic Juvenile Idiopathic Arthritis.Systemic Juvenile Idiopathic Arthritis (sJIA)MedDRA version: 18.0Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-000435-33-HUF. Hoffmann-La Roche Ltd10
进行中（未招募）
1 期
A study to assess the pharmacokinetics and safety of tocilizumab in patients less than 2 years old with Active Systemic Juvenile Idiopathic Arthritis.Systemic Juvenile Idiopathic Arthritis (sJIA)MedDRA version: 19.0Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-000435-33-BEF. Hoffmann-La Roche Ltd10